Skip to main navigation Skip to search Skip to main content

Prevention of posterior capsule opacification by retinoic acid and mitomycin

  • Ümit U. Inan
  • , Faruk Öztürk
  • , SÜleyman Kaynak
  • , SÜleyman S. Ilker
  • , Erdener Özer
  • , Cenap Güler

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Abstract

Background: Our aim was to evaluate the effect of an intraoperative single dose of retinoic acid (RA) or mitomycin C (MMC) in preventing posterior capsule opacification (PCO). Methods: Twenty-seven rabbits were divided randomly into three groups. RA (250 μg/ml) and MMC (0.04 mg/ml) were given 0.1 ml by hydrosection and 0.9 ml into the capsular bag after phacoemulsification. The third group served as a control group. Three months after intervention PCO was graded clinically. Furthermore, proliferation of lens epithelial cells was evaluated histologically. Results: Two eyes developed corneal edema in the MMC group. On clinical assessment, RA and MMC were significantly effective in preventing PCO compared with controls (P<0.005). On histological analysis, there was significantly reduced proliferative activity on posterior capsules in the treatment groups, in contrast to multi-layer cells in the control group. Conclusion: Intraoperative single-dose administration of RA and MMC significantly prevented the development of PCO in rabbit eyes. The optimal biocompatible dosage must be carefully determined by further investigation.

Original languageEnglish
Pages (from-to)693-697
Number of pages5
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume239
Issue number9
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Dive into the research topics of 'Prevention of posterior capsule opacification by retinoic acid and mitomycin'. Together they form a unique fingerprint.

Cite this